Last update 13 Dec 2025

CD19-TriCAR SILK cell therapy (Timmune Biotech)

Overview

Basic Info

Drug Type
CAR-NK
Synonyms
Allogeneic tri-functional CAR-NK cell therapy, CD19-TriCAR-T/SILK, CD19TriCARSILK Timmune Biotech
Target
CD19
Action
inhibitors
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference(Gene transference), Natural killer cell replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
CD19 Positive LymphomaCD19 positive Non-Hodgkin LymphomaNon-Hodgkin's lymphoma refractory
Originator Organization
TimmuneTimmune
Active Organization-
Inactive Organization
TimmuneTimmune
License Organization-
Drug Highest PhasePendingEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with CD19-TriCAR SILK cell therapy (Timmune Biotech)
NCT03910842
/ Unknown statusEarly Phase 1
Adoptive Immunotherapy for Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell
NCT03790891
/ Unknown statusEarly Phase 1
Adoptive Immunotherapy for Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell
100 Clinical Results associated with CD19-TriCAR SILK cell therapy (Timmune Biotech)
Login to view more data
100 Translational Medicine associated with CD19-TriCAR SILK cell therapy (Timmune Biotech)
Login to view more data
100 Patents (Medical) associated with CD19-TriCAR SILK cell therapy (Timmune Biotech)
Login to view more data
100 Deals associated with CD19-TriCAR SILK cell therapy (Timmune Biotech)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD19 Positive LymphomaPhase 1
China
TimmuneTimmune
21 Mar 2019
CD19 positive Non-Hodgkin LymphomaPhase 1
China
TimmuneTimmune
05 Jan 2019
Non-Hodgkin's lymphoma refractoryPhase 1
China
TimmuneTimmune
05 Jan 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free